Flow Traders NV
REPURCHASE OF SHARES
Amsterdam, the Netherlands - Flow Traders N.V. ("Flow Traders") (Euronext: FLOW) has repurchased 40,200 of its own shares in the period from 11 March 2021 up to and including 17 March 2021 at an average price of €35.39.
As announced on 12 February 2021, these repurchases are being made in order to satisfy the requirements of various employee incentive plans. The consideration of this purchase was €1.4 million.
The total number of shares purchased under this programme to date is 598,196 shares at an average price of €33.99 for a total consideration of €20.3 million.
2,527,188 shares were held in treasury as at 17 March 2021.
Contact Details
Flow Traders N.V.
Jonathan Berger / Investor Relations Officer
Phone: +31 20 7996799
Email: investor.relations@flowtraders.com
About Flow Traders
Flow Traders is a leading global financial technology-enabled liquidity provider in financial products, historically specialized in Exchange Traded Products (ETPs), now expanding into other asset classes. Flow Traders ensures the provision of liquidity to support the uninterrupted functioning of financial markets. This allows investors to continue to buy or sell ETPs or other financial instruments under all market circumstances. We continuously grow our organization, ensuring that our trading desks in Europe, the Americas and Asia can provide liquidity across all major exchanges, globally, 24 hours a day. Founded in 2004, we continue to cultivate the entrepreneurial, innovative and team-oriented culture that has been with us since the beginning.
Important Legal Information
This press release is prepared by Flow Traders N.V. and is for information purposes only. It is not a recommendation to engage in investment activities and you must not rely on the content of this document when making any investment decisions. The information in this document does not constitute legal, tax, or investment advice and is not to be regarded as investor marketing or marketing of any security or financial instrument, or as an offer to buy or sell, or as a solicitation of any offer to buy or sell, securities or financial instruments.
The information and materials contained in this press release are provided ‘as is’ and Flow Traders N.V. or any of its affiliates ("Flow Traders") do not warrant the accuracy, adequacy or completeness of the information and materials and expressly disclaim liability for any errors or omissions. This press release is not intended to be, and shall not constitute in any way a binding or legal agreement, or impose any legal obligation on Flow Traders. All intellectual property rights, including trademarks, are those of their respective owners. All rights reserved. All proprietary rights and interest in or connected with this publication shall vest in Flow Traders. No part of it may be redistributed or reproduced without the prior written permission of Flow Traders.
Flow Traders expressly disclaims any obligation or undertaking to update, review or revise any forward-looking statements contained in this press release to reflect any change in its expectations or any change in events, conditions or circumstances on which such statements are based unless required to do so by applicable law.
By accepting this document you agree to the terms set out above. If you do not agree with the terms set out above please notify legal.amsterdam@nl.flowtraders.com immediately and delete or destroy this document.
Market Abuse Regulation
This press release is an announcement pursuant to Article 5 (1) of the EU Market Abuse Regulation.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG25.10.2025 17:00:00 CEST | Press release
Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
Jelenew25.10.2025 16:21:00 CEST | Press release
World Champion Marion Clignet’s Journey: One More Kilometer, 30 Years on the Road.
Debit My Data, Inc.24.10.2025 21:42:27 CEST | Press release
DebitMyData Addresses Global H20 Export Ban Crisis, Unveils Critical Role of the Human Energy Grid
International Dialogue Centre - KAICIID24.10.2025 18:23:17 CEST | Press release
KAICIID Convenes the 6th European Policy Dialogue Forum (EPDF) to Renew Shared Values in a Fragmented Europe
Damac Properties Dubai Co. PJSC24.10.2025 18:02:55 CEST | Press release
DAMAC Invites the World to Apply for “The Ultimate DAMAC Islander”
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
